Neutral
Vanguard reports 3.53M-share stake in Protagonist Therapeutics (NASDAQ: PTGX)
Vanguard Portfolio Management has reported a beneficial ownership of 3,533,015 shares, representing a 5.53% stake, in Protagonist Therapeutics (NASDAQ...